Trademark Overview
On Wednesday, March 11, 2026, a trademark application was filed for PROSCIENTO THE METABOLIC CONTINUUM CRO with the United States Patent and Trademark Office. The USPTO has given the PROSCIENTO THE METABOLIC CONTINUUM CRO trademark a serial number of 99696100. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, March 11, 2026. This trademark is owned by ProSciento, Inc.. The PROSCIENTO THE METABOLIC CONTINUUM CRO trademark is filed in the Advertising, Business and Retail Services category with the following description:
Business consulting and project management in the fields of clinical trials and metabolic health, namely, providing information management services; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes and management of clinical trial execution by providing independent review of clinical trials for business purposes; business consulting and management in the field of clinical trials, namely, management of clinical trial execution; providing technical consulting services in the field of marketing and advertising for clinical trials, verifying clinical trial subject eligibility for clinical trials, clinical trial subject recruitment and enrollment for clinical trials, and processing business documents relating to clinical trials, and information management services, namely, clinical data management to medical, pharmaceutical and technology companies in order t...
